By Editorial TeamFDA Regulatory Clearance data is a primary, independently verifiable signal for AI healthcare company evaluation. This data precedes any vendor pitch. Regulatory Clearance Score quantifies this signal, converting public records into a comparable metric.
Clearance Record Components
A clearance record details a medical device’s regulatory journey. This includes the submission pathway, such as 510(k) or De Novo Classification. It also notes any special designations. Breakthrough Device Designation is one such example. These records establish a device’s intended use and performance claims.
Regulatory Pathway Progression
The regulatory route begins with a submission to the FDA. This filing outlines the device’s technical specifications and clinical data. For many AI healthcare products, this involves demonstrating substantial equivalence to a predicate device via the 510(k) pathway. Novel devices with no predicate device pursue De Novo Classification. This pathway is for low-to-moderate-risk devices. Breakthrough Device Designation expedites review for devices addressing life-threatening or irreversibly debilitating conditions. Cardiology leads in Breakthrough Device Designations, with 260 recorded. FDA Breakthrough Devices Program overview
Recorded Vendor Set Clearance Status
HeartFlow, Tempus AI, and Butterfly Network demonstrate diverse clearance records. These companies operate within Cardiac AI and medical imaging. Their materials rest on cleared routes.
HeartFlow Clearance
HeartFlow focuses on non-invasive cardiac diagnostics. Their HeartFlow FFRct Analysis received FDA De Novo classification. This device aids in diagnosing coronary artery disease. It provides fractional flow reserve (FFR) values from computed tomography (CT) scans. The company has built a patent thicket around CT-FFR. HeartFlow FDA 510(k) clearance documentation
Tempus AI Clearance
Tempus AI leverages AI for precision medicine. Their clearances span various oncology and genomic diagnostics. Tempus xT, for instance, is a genomic sequencing assay cleared by the FDA. While primarily known for oncology, their AI platform’s capabilities extend to broader diagnostic applications. The company utilizes a data moat from proprietary datasets.
Butterfly Network Clearance
Butterfly Network develops a portable ultrasound device. The Butterfly iQ3 received FDA clearance. This device integrates AI for image acquisition and interpretation. It functions as a SaMD (Software as a Medical Device). The Butterfly iQ3 is a wedge product, gaining market entry through a focused offering.
Regulatory Clearance Score Application
The Regulatory Clearance Score synthesizes these regulatory events. Each clearance, designation, and pathway contributes to the score. A 510(k) clearance provides a baseline. De Novo classification indicates greater novelty. Breakthrough Device Designation adds significant weight due to its stringent criteria and expedited review. This scoring methodology provides an objective, comparable signal. It functions independently of marketing claims.
Procurement Verification Steps
Procurement teams can verify these records. The FDA website (fda.gov) provides a searchable database of cleared devices. PubMed (pubmed.ncbi.nlm.nih.gov) hosts clinical studies supporting these clearances. ClinicalTrials.gov offers details on registered clinical trials. This allows for independent validation of a vendor’s regulatory claims. A buyer can follow each route from filing to designation without direct vendor interaction. This pre-pilot check is critical for de-risking procurement decisions. FDA medical device database search
Frequently Asked Questions
What is the purpose of reviewing FDA clearance records before a pilot?
Reviewing FDA clearance records serves as a primary, independently verifiable signal for evaluating AI healthcare companies. This data precedes any vendor pitch and is critical for de-risking procurement decisions by validating a vendor’s regulatory claims.
What information can be found in a clearance record?
A clearance record details a medical device’s regulatory journey, including the submission pathway (e.g., 510(k) or De Novo Classification) and any special designations like Breakthrough Device Designation. These records establish a device’s intended use and performance claims.
How can procurement teams independently verify a vendor’s FDA clearance claims?
Procurement teams can verify these records through the FDA website’s searchable database of cleared devices. Additional validation can be found on PubMed for clinical studies and ClinicalTrials.gov for registered clinical trials, allowing for independent verification without direct vendor interaction.
What is the significance of a De Novo Classification versus a 510(k) clearance?
A 510(k) clearance demonstrates substantial equivalence to a predicate device, providing a baseline regulatory approval. De Novo Classification, however, indicates greater novelty for low-to-moderate-risk devices that have no predicate device, signifying a more unique regulatory pathway.
